How Newcomer was paid
$2.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Other | Total |
|---|---|---|---|---|---|
| Mark R. NewcomerCEO | $1,050,000 | $301,865 | $1,398,000 | $4,400 | $2,754,265 |
| Matthew TurnerPresident, Patient Affordability | $444,987 | $282,039 | $815,500 | — | $1,542,526 |
| Michael NgoChief Innovation Officer | $295,385 | $1,865 | $1,190,000 | $2,462 | $1,489,712 |
What changed and why
- $2.8MCEO total compensation increased to $2,754,265 in fiscal 2025.
- $1.4MMark R. Newcomer received $1,398,000 in stock awards during the year.
- Bonuses paid were discretionary and determined by the Board.
- $1.5MMichael Ngo was appointed Chief Innovation Officer and received $1,489,712 in total compensation.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.